CD8 + TILs in NSCLC differentiate into TEMRA via a bifurcated trajectory: deciphering immunogenicity of tumor antigens.
Sung-Woo LeeHe Yun ChoiGil-Woo LeeTherasa KimHyun-Ju ChoIn-Jae OhSang Yun SongDeok Hwan YangJae-Ho ChoPublished in: Journal for immunotherapy of cancer (2022)
TIL counts, a reliable biomarker for successful cancer immunotherapy.